LAWTON VINCENT MICHAEL enters ADDEX THERAPEUTICS LTD. with 2.51M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/25/2026ACC: 0001104659-26-034501
Director
Since Mar 2026
2.51M
Baseline shares
100% direct
2.51M
Direct ownership
1 position
501.60K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned2.51M
Total
2.51M direct2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.51M | Direct |
| Total | 2.51M | 2.51M direct |
Derivative Holdings1
Stock-Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
501.60K
Shares owned
N/A
Exercise price
0.064
Expiration
—
Exercise window
—
Total
Underlying
501.60K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock-Option (Right to Buy) Direct | Common Stock | 0.064 | — | — | 501.60K | N/A |
| Total | 501.60K | 0.00 | ||||